sulpiride has been researched along with EHS Tumor in 1 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, T | 1 |
| Fetissov, SO | 1 |
| Meguid, MM | 1 |
| Miyata, G | 1 |
| Chen, C | 1 |
1 other study available for sulpiride and EHS Tumor
| Article | Year |
|---|---|
Intra-supraoptic nucleus sulpiride improves anorexia in tumor-bearing rats.
Topics: Animals; Anorexia; Body Weight; Dopamine Antagonists; Eating; Hypothalamus, Anterior; Male; Rats; Ra | 2001 |